Development of the antimicrobial effectiveness test as USP chapter .

Area of Science:

• Pharmaceutical Science
• Microbiology
• Regulatory Science

Background:

• The antimicrobial effectiveness test was introduced in USP General Chapter in 1970.
• Initially, it evaluated antimicrobials added to prevent microbial growth during manufacturing.
• Its purpose shifted to assessing preservative system efficacy against contamination during product storage and use, aligning with Good Manufacturing Practices (GMPs).

Purpose of the Study:

• To review the historical evolution of the antimicrobial effectiveness test in the United States Pharmacopeia (USP).
• To examine the test's function, methodology, and the rationale behind its revisions.
• To compare the initial USP XVIII test with the current USP 25 version.

Main Methods:

• Historical review of USP General Chapters related to antimicrobial effectiveness.
• Analysis of the functional and technical changes in the test methodology over time.
• Examination of the regulatory and scientific discussions influencing test revisions.

Main Results:

• The test's focus shifted from controlling microbial introduction during manufacturing to ensuring preservative efficacy during product lifecycle.
• Refinements in the test methodology reflect advancements in pharmaceutical manufacturing standards and regulatory expectations.
• Significant changes occurred between the USP XVIII and USP 25 versions, impacting how preservative systems are evaluated.

Conclusions:

• The antimicrobial effectiveness test has adapted to evolving pharmaceutical manufacturing standards and regulatory requirements.
• The test remains crucial for safeguarding product integrity against microbial contamination.
• Understanding the historical context of the test is vital for interpreting current methodologies and future revisions.